Cigna Raises 2026 Adjusted EPS Guidance to at Least $30.60

• Cigna raised 2026 adjusted EPS guidance by $0.15 to at least $30.60, following third-quarter adjusted EPS of $7.98 that exceeded expectations.
• Healthcare pre-tax adjusted operating income guidance increased $50 million to at least $4.6 billion; Evernorth’s forecast remained at least $6.9 billion.
• The medical care ratio forecast narrowed to 84.2%, plus or minus 25 basis points, from 83.7%-84.7%.
• For 2027, adjusted EPS growth remains projected at least 10% above the ongoing-business run-rate baseline of at least $30.
• Expected growth drivers include improved stop-loss margins, strong sales and productivity gains, offset partly by the ACA exchange exit and pharmacy pressures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The CIGNA Corporation published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.